Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / NY ARCA BIOTECH
-
Number of holders
-
127
-
Total 13F shares, excl. options
-
21,779,226
-
Shares change
-
+1,431,913
-
Total reported value, excl. options
-
$2,459,415,016
-
Value change
-
+$164,656,445
-
Put/Call ratio
-
19%
-
Number of buys
-
64
-
Number of sells
-
-60
-
Price
-
$113.02
Significant Holders of FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) as of Q4 2015
151 filings reported holding FBT - FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH as of Q4 2015.
FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) has 127 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 21,779,226 shares
.
Largest 10 shareholders include FIRST TRUST ADVISORS LP (10,731,173 shares), MORGAN STANLEY (2,810,647 shares), WELLS FARGO & COMPANY/MN (1,907,279 shares), UBS Group AG (989,729 shares), BANK OF AMERICA CORP /DE/ (888,418 shares), LPL Financial LLC (602,993 shares), RAYMOND JAMES & ASSOCIATES (454,784 shares), Raymond James Financial Services Advisors, Inc. (324,345 shares), Transamerica Financial Advisors, Inc. (228,985 shares), and MetLife Securities, Inc (207,089 shares).
This table shows the top 127 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.